Sexual and Reproductive Health Care Utilization and Preferences of Young Women With Cystic Fibrosis

An abstract of a study by Kazmerski et al identifying sexual and reproductive health (SRH) care utilization patterns and preferences toward SRH care delivery of young women with cystic fibrosis (CF) is presented. Results showed that of 186 women with CF (mean age 19.7±2.8 years) have completed the s...

Full description

Saved in:
Bibliographic Details
Published in:Journal of adolescent health 2017-02, Vol.60 (2), p.S35-S36
Main Authors: Kazmerski, Traci M., MD, Borrero, Sonya, MD, Sawicki, Gregory, MD, MPH, Jones, Kelley A., PhD, Abebe, Kaleab Z., PhD, Tuchman, Lisa K., MD, MPH, FSAHM, Ladores, Sigrid, PhD, RN, Pilewski, Joseph M., MD, Rubenstein, Ron C., MD, PhD, Sagel, Scott D., MD, PhD, Weiner, Daniel J., MD, Orenstein, David, MD, Miller, Elizabeth, MD, PhD, FSAHM
Format: Article
Language:English
Subjects:
Birth control
Contraceptives
Counseling
Cystic fibrosis
Family planning
Family therapy
Health services utilization
Health status
Help seeking behavior
Human papillomavirus
Immunization
Menstruation
Pediatrics
Pregnancy
Puberty
Reproductive health
Sexually transmitted diseases
STD
Teams
Women
Young women
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An abstract of a study by Kazmerski et al identifying sexual and reproductive health (SRH) care utilization patterns and preferences toward SRH care delivery of young women with cystic fibrosis (CF) is presented. Results showed that of 186 women with CF (mean age 19.7±2.8 years) have completed the survey. NSFG comparison data from 2011- 2013 was available for 1997 women ages 15-24 years (mean age 19.6+0.1 years). Of women with CF, 38% had ever sought contraception and 9% reported contraceptive counseling, compared to national estimates of 44%, and 26% for these ser- vices, respectively. Women with CF also had lower rates of obtaining a pregnancy test (8% vs. 24%); undergoing a Pap smear or pelvic exam (26% vs. 44%); and receiving STI testing, counseling, or treatment (9% vs. 23%) compared to U.S. women. HPV vaccination rate was similar (44% vs. 43%). A minority of women with CF reported receiving SRH services from their CF team (12% received a contraceptive method or prescription, 7% pregnancy testing, 4% pregnancy or family planning counseling, 4% HPV vaccination, and 2% STI testing, counseling, or treatment). Seventy-three percent of women with CF reported ever discussing puberty or menstruation with their CF team: a minority of women reported discussing other SRH topics.
ISSN:1054-139X
1879-1972
DOI:10.1016/j.jadohealth.2016.10.087